Skip to content
2000
Volume 25, Issue 8
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Berbamine (Ber) is an active medicinal bisbenzylisoquinoline alkaloid, which is usually obtained from different plants of the genus (family ) and is used to cure various disorders in traditional Chinese and Ayurvedic systems of medicine. Numerous and studies revealed the apoptotic and cytotoxic potential of Ber against different cell lines (SMMC-7721, A549, MDA-MB-231, and K562) by upregulating pro-apoptotic (Bax, p53) and downregulating anti-apoptotic (Bcl-2, survivin) proteins. Other pharmacological attributes ascribed to Ber included cardioprotective, anti-diabetic, anti-inflammatory, antimalarial, antioxidant, anti-hypercholesterolemic, and anti-allergic. Moreover, the synergistic effect of Ber improved the therapeutic potential of different drugs (paclitaxel (PTL), gemcitabine, dexamethasone, doxorubicin (DOX), and celecoxib) in different models. Various attempts could fabricate biologically active derivatives of Ber, such as 4-chlorobenzoyl berbamine (CBB) and -4-ethoxyl-butyl-berbamine (EBB). The review focuses on the medicinal applications of Ber, particularly anti-cancer, cardioprotective, and anti-inflammatory, along with the mechanism of action.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ctmc/10.2174/0115680266289292240420062705
2024-04-29
2025-09-02

  • From This Site

    /content/journals/ctmc/10.2174/0115680266289292240420062705
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. CaoY. CaoJ. YuB. Berbamine induces SMMC-7721 cell apoptosis via upregulating p53, downregulating survivin expression and activating mitochondria signaling pathway.Exp. Ther. Med.201815218941901 29434780
     [Google Scholar]
  2. ZhengY. GuS. LiX. Berbamine postconditioning protects the heart from ischemia/reperfusion injury through modulation of autophagy.Cell Death Dis.201782e257710.1038/cddis.2017.7 28151484
     [Google Scholar]
  3. HanB. KouS. HeK. Anti-hypercholesterolemic effect of berbamine isolated from Rhizoma Coptidis in hypercholesterolemic zebrafish induced by high-cholesterol diet.Iran. J. Pharm. Res.2018171292306 29755560
     [Google Scholar]
  4. JiaX.J. LiX. WangF. LiuH.Q. ZhangD.J. ChenY. Berbamine exerts anti-inflammatory effects via inhibition of NF-κB and MAPK signaling pathways.Cell. Physiol. Biochem.20174162307231810.1159/000475650 28456802
     [Google Scholar]
  5. SongX.Y. KongL.L. ChenN.H. Berbamine. In: Natural Small Molecule Drugs from Plants.2018485489
     [Google Scholar]
  6. BaseraI.A. GirmeA. BhattV.P. ShahM.B. A validated high-performance thin-layer chromatography method for the simultaneous estimation of berberine, berbamine, palmatine, magnoflorine and jatrorrhizine from Berberis aristata.J. Planar Chromatogr. Mod. TLC202134214715510.1007/s00764‑021‑00094‑9
     [Google Scholar]
  7. LiangY. QiuX. XuR. ZhaoX. Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity.J. Zhejiang Univ. Sci. B201112756857410.1631/jzus.B1000230 21726064
     [Google Scholar]
  8. JiaF. RuanS. LiuN. FuL. Synergistic antitumor effects of berbamine and paclitaxel through ROS/Akt pathway in glioma cells.Evid Comp Alter Med2017
     [Google Scholar]
  9. MengZ. LiT. MaX. Berbamine inhibits the growth of liver cancer cells and cancer-initiating cells by targeting Ca2+/calmodulin-dependent protein kinase II.Mol. Cancer Ther.201312102067207710.1158/1535‑7163.MCT‑13‑0314 23960096
     [Google Scholar]
  10. SankaranarayananC. NishanthiR. PugalendiP. Ameliorating effect of berbamine on hepatic key enzymes of carbohydrate metabolism in high-fat diet and streptozotocin induced type 2 diabetic rats.Biomed. Pharmacother.201810353954510.1016/j.biopha.2018.04.066 29677540
     [Google Scholar]
  11. JuH. LiX. ZhaoB. HanZ. XinW. Scavenging effect of berbamine on active oxygen radicals in phorbol ester-stimulated human polymorphonuclear leukocytes.Biochem. Pharmacol.199039111673167810.1016/0006‑2952(90)90110‑7 2160816
     [Google Scholar]
  12. FarooqiA.A. WenR. AttarR. TavernaS. ButtG. XuB. Regulation of cell-signaling pathways by berbamine in different cancers.Int. J. Mol. Sci.2022235275810.3390/ijms23052758 35269900
     [Google Scholar]
  13. DuanH. LuanJ. LiuQ. YagasakiK. ZhangG. Suppression of human lung cancer cell growth and migration by berbamine.Cytotechnology201062434134810.1007/s10616‑009‑9240‑x 19967402
     [Google Scholar]
  14. GuY. ChenT. MengZ. CaMKII γ a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine.Blood2012120244829483910.1182/blood‑2012‑06‑434894 23074277
     [Google Scholar]
  15. LingZ.Y. PingT.Y. FenQ.G. HongZ. YanL.B. HanL.W. Effects of berbamine on cytosolic free calcium in cultured vascular smooth muscle cells.Chin Pharmacol Bull2000427
     [Google Scholar]
  16. SaranyaS. BaskaranR. PoornimaP. Vijaya PadmaV. Berbamine ameliorates isoproterenol-induced myocardial infarction by inhibiting mitochondrial dysfunction and apoptosis in rats.J. Cell. Biochem.201912033101311310.1002/jcb.27522 30485494
     [Google Scholar]
  17. ZhangC.M. GaoL. ZhengY.J. YangH.T. Berbamine protects the heart from ischemia/reperfusion injury by maintaining cytosolic Ca(2+) homeostasis and preventing calpain activation.Circ. J.20127681993200210.1253/circj.CJ‑11‑1431 22664727
     [Google Scholar]
  18. VitelloR. TaoubaH. DerandM. LiégeoisJ.F. The Bis(1,2,3,4-tetrahydroisoquinoline) Alkaloids Cepharanthine and Berbamine Are Ligands of SK Channels.ACS Med. Chem. Lett.202415221522010.1021/acsmedchemlett.3c00452 38352826
     [Google Scholar]
  19. ZhuH. RuanS. JiaF. In vitro and in vivo superior radiosensitizing effect of berbamine for head and neck squamous cell carcinoma.OncoTargets Ther.2018118117812510.2147/OTT.S171212 30532553
     [Google Scholar]
  20. JinX. WuY. Berbamine enhances the antineoplastic activity of gemcitabine in pancreatic cancer cells by activating transforming growth factor-β/Smad signaling.Anat. Rec. (Hoboken)2014297580280910.1002/ar.22897 24619961
     [Google Scholar]
  21. LiangY. XuR. ZhangL. ZhaoX. Berbamine, a novel nuclear factor κB inhibitor, inhibits growth and induces apoptosis in human myeloma cells.Acta Pharmacol. Sin.200930121659166510.1038/aps.2009.167 19960011
     [Google Scholar]
  22. ZhaoY. TanY. WuG. Berbamine overcomes imatinib-induced neutropenia and permits cytogenetic responses in Chinese patients with chronic-phase chronic myeloid leukemia.Int. J. Hematol.201194215616210.1007/s12185‑011‑0887‑7 21728004
     [Google Scholar]
  23. DuH.P. ShenJ.K. YangM. 4-Chlorobenzoyl berbamine induces apoptosis and G2/M cell cycle arrest through the PI3K/Akt and NF-kappaB signal pathway in lymphoma cells.Oncol. Rep.2010233709716 20127010
     [Google Scholar]
  24. FangB.J. YuM.L. YangS.G. LiaoL.M. LiuJ.W. ZhaoR.C.H. Effect of O-4-ethoxyl-butyl-berbamine in combination with pegylated liposomal doxorubicin on advanced hepatoma in mice.World J. Gastroenterol.200410795095310.3748/wjg.v10.i7.950 15052672
     [Google Scholar]
  25. WuS.G. ZhangG.L. Synthesis and antitumor activity in vitro of novel berbamine derivatives.J. Asian Nat. Prod. Res.2020111 32406754
     [Google Scholar]
  26. MiuraK. SatohM. KinouchiM. The use of natural products in colorectal cancer drug discovery.Expert Opin. Drug Discov.201510441142610.1517/17460441.2015.1018174 25724579
     [Google Scholar]
  27. MarahathaR. ShresthaA. SharmaK. In silico study of alkaloids: Neferine and berbamine potentially inhibit the SARS-CoV-2 RNA-dependent RNA polymerase.J. Chem.202220221910.1155/2022/7548802
     [Google Scholar]
  28. FuR. DengQ. ZhangH. A novel autophagy inhibitor berbamine blocks SNARE-mediated autophagosome-lysosome fusion through upregulation of BNIP3.Cell Death Dis.20189224310.1038/s41419‑018‑0276‑8 29445175
     [Google Scholar]
  29. MuhammadG. HussainM.A. AnwarF. AshrafM. GilaniA.H. Alhagi: a plant genus rich in bioactives for pharmaceuticals.Phytother. Res.201529111310.1002/ptr.5222 25256791
     [Google Scholar]
  30. SaleemS. MuhammadG. HussainM.A. BukhariS.N.A. A comprehensive review of phytochemical profile, bioactives for pharmaceuticals, and pharmacological attributes of Azadirachta indica.Phytother. Res.20183271241127210.1002/ptr.6076 29671907
     [Google Scholar]
  31. NazarS. HussainM.A. KhanA. MuhammadG. TahirM.N. Capparis decidua Edgew (Forssk.): A comprehensive review of its traditional uses, phytochemistry, pharmacology and nutrapharmaceutical potential.Arab. J. Chem.20201311901191610.1016/j.arabjc.2018.02.007
     [Google Scholar]
  32. AnwarF. MuhammadG. HussainM.A. Capparis spinosa L.:A plant with high potential for development of functional foods and nutraceuticals/pharmaceuticals.Int. J. Pharmacol.201612320121910.3923/ijp.2016.201.219
     [Google Scholar]
  33. AshrafM.U. MuhammadG. HussainM.A. BukhariS.N.A. Cydonia oblonga M., a medicinal plant rich in phytonutrients for pharmaceuticals.Front. Pharmacol.2016716310.3389/fphar.2016.00163 27445806
     [Google Scholar]
  34. MuhammadG. HussainM.A. JantanI. BukhariS.N.A. Mimosa pudica L., a high-value medicinal plant as a source of bioactives for pharmaceuticals.Compr. Rev. Food Sci. Food Saf.201615230331510.1111/1541‑4337.12184 33371596
     [Google Scholar]
  35. LiH. LuoK. YangZ. Berbamine suppresses the growth of gastric cancer cells by inactivating the BRD4/c-MYC signaling pathway.Drug Des. Devel. Ther.20221612914110.2147/DDDT.S338881 35046638
     [Google Scholar]
  36. HanC WangZ ChenS Berbamine suppresses the progression of bladder cancer by modulating the ROS/NF-κB Axis.Oxidative Med Cell longev20212021
     [Google Scholar]
  37. ZhangH. ZhouY. IbrahimI.A.A. ChengW. LiuH. Iron oxide-alginate-berbamine nanocomposites trigger reactive oxygen species-induced apoptosis through down-regulation of PI3K/AKT signaling in human bladder cancer cells.Process Biochem.202212234134910.1016/j.procbio.2022.10.003
     [Google Scholar]
  38. GuoS. ZhangZ. CaoL. WuT. LiB. CuiY. Nanocomposites containing ZnO-TiO2-Chitosan and berbamine promote osteoblast differentiation, proliferation, and calcium mineralization in MG63 osteoblasts.Process Biochem.2023124637010.1016/j.procbio.2022.11.004
     [Google Scholar]
  39. YangS. YangS. ZhangH. Targeting Na +/K + -ATPase by berbamine and ouabain synergizes with sorafenib to inhibit hepatocellular carcinoma.Br. J. Pharmacol.2021178214389440710.1111/bph.15616 34233013
     [Google Scholar]
  40. LiuL. YanJ. CaoY. Proliferation, migration and invasion of triple negative breast cancer cells are suppressed by berbamine via the PI3K/Akt/MDM2/p53 and PI3K/Akt/mTOR signaling pathways.Oncol. Lett.20202117010.3892/ol.2020.12331 33365081
     [Google Scholar]
  41. LiuL. XuZ. YuB. TaoL. CaoY. Berbamine inhibits cell proliferation and migration and induces cell death of lung cancer cells via regulating c-Maf, PI3K/Akt, and MDM2-P53 pathways.Evid. Based Complement. Alternat. Med.2021202112010.1155/2021/5517143 34306137
     [Google Scholar]
  42. TaoL YanJ-d Effects of berbamine on proliferation and apoptosis of human lung cancer cells and the mechanism.2023
     [Google Scholar]
  43. KathemS.H. AbdulsahibW.K. ZalzalaM.H. Berbamine and thymoquinone exert protective effects against immune-mediated liver injury via NF-κB dependent pathway.Front. Vet. Sci.2022996098110.3389/fvets.2022.960981 35958317
     [Google Scholar]
  44. HouZ.B. LuK.J. WuX.L. ChenC. HuangX.E. YinH.T. In vitro and in vivo antitumor evaluation of berbamine for lung cancer treatment.Asian Pac. J. Cancer Prev.20141541767176910.7314/APJCP.2014.15.4.1767 24641406
     [Google Scholar]
  45. LiS.Y. JeiW. SeowW.K. ThongY.H. Effect of berbamine on blood and bone-marrow stem cells of cyclophosphamide-treated mice.Int. J. Immunopharmacol.199416324524910.1016/0192‑0561(94)90019‑1 8206691
     [Google Scholar]
  46. FournetA. BarriosA.A. MuñozV. HocquemillerR. CavéA. Effect of some bisbenzylisoquinoline alkaloids on American Leishmania sp. in BALB/c mice.Phytother. Res.19937428128410.1002/ptr.2650070404
     [Google Scholar]
  47. AkibaS. NagatomoR. IshimotoT. SatoT. Effect of berbamine on cytosolic phospholipase A2 activation in rabbit platelets.Eur. J. Pharmacol.1995291334335010.1016/0922‑4106(95)90075‑6 8719419
     [Google Scholar]
  48. HashizumeT. YamaguchiH. SatoT. FujiiT. Suppressive effect of biscoclaurine alkaloids on agonist-induced activation of phospholipase A2 in rabbit platelets.Biochem. Pharmacol.199141341942310.1016/0006‑2952(91)90539‑H 1899790
     [Google Scholar]
  49. YasukawaK. AkasuM. TakeuchiM. TakidoM. Bisbenzylisoquinoline alkaloids inhibit tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin.Oncology199350213714010.1159/000227165 8451036
     [Google Scholar]
  50. WangG.Y. LvQ.H. DongQ. XuR.Z. DongQ.H. Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice.J. Asian Nat. Prod. Res.200911321922810.1080/10286020802675076 19408145
     [Google Scholar]
  51. WangS. LiuQ. ZhangY. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.Mol. Cancer2009818110.1186/1476‑4598‑8‑81 19796390
     [Google Scholar]
  52. WeiY.L. LiangY. XuL. ZhaoX.Y. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway.Anat. Rec. (Hoboken)2009292794595010.1002/ar.20924 19548306
     [Google Scholar]
  53. WeiY. XuL. LiangY. XuX. ZhaoX. Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo.Acta Pharmacol. Sin.200930445145710.1038/aps.2009.19 19270722
     [Google Scholar]
  54. WeiY.L. XuL. ZhaoX.Y. Mechanism related to inhibition of leukemia K562 cells by berbamine.Zhejiang Da Xue Xue Bao Yi Xue Ban2009384387391 19693977
     [Google Scholar]
  55. WuD. LinM. The effects of berbamine in nude mice xenograft model of human leukemic cells.Blood200510611441310.1182/blood.V106.11.4413.4413
     [Google Scholar]
  56. WuD. LinM. ZhaoX. XuR. Apoptosis induced by berbamine in K562 cells correlates with the expression levels of bcr/abl gene and P210.Chin J Pathophysiol20042013961401
     [Google Scholar]
  57. LinM. WuD. Berbamine induces apoptosis and lowers expression levels of bcr/abl and survivin gene and bcr/abl-related p210 in different types of leukemic cell lines cells.Blood200410411435610.1182/blood.V104.11.4356.4356
     [Google Scholar]
  58. ZhaoX. XuL. WuD. XuR. Berbamine-induced apoptosis in human leukemia K562 cells.Blood200410411423410.1182/blood.V104.11.4234.4234
     [Google Scholar]
  59. DongQ.H. ZhengS. XuR.Z. LuQ. HeL. Study on effect of berbamine on multidrug resistance leukemia K562/Adr cells.Chung Kuo Chung Hsi I Chieh Ho Tsa Chih2004249820822 15495829
     [Google Scholar]
  60. LiangY. ZhaoX.Y. WeiY.L. XuR.Z. Berbamine induces apoptosis of multiple myeloma RPMI 8226 cells by activating GADD45/JNK pathway.Zhejiang Da Xue Xue Bao Yi Xue Ban2009385439444 19830854
     [Google Scholar]
  61. ZhaoX. HeZ. WuD. XuR. Berbamine selectively induces apoptosis of human acute promyelocytic leukemia cells via survivin-mediated pathway.Chin. Med. J.2007120980280610.1097/00029330‑200705010‑00012 17531122
     [Google Scholar]
  62. ZhaoX. HeZ. WuD. XuR. Studies on the effects of berbamine on the human leukemia cell line NB4.Blood200510611442210.1182/blood.V106.11.4422.4422
     [Google Scholar]
  63. ZhangH. JiaoY. ShiC. Berbamine suppresses cell viability and induces apoptosis in colorectal cancer via activating p53-dependent apoptotic signaling pathway.Cytotechnology201870132132910.1007/s10616‑017‑0146‑8 28965196
     [Google Scholar]
  64. ZhanY. ChenQ. SongY. Berbamine Hydrochloride inhibits lysosomal acidification by activating Nox2 to potentiate chemotherapy-induced apoptosis via the ROS-MAPK pathway in human lung carcinoma cells.Cell Biol. Toxicol.20233941297131710.1007/s10565‑022‑09756‑8 36070022
     [Google Scholar]
  65. XuR. DongQ. YuY. Berbamine: A novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity.Leuk. Res.2006301172310.1016/j.leukres.2005.05.023 16023722
     [Google Scholar]
  66. JiZ.N. YeW.C. LiuG.Q. HuangY. Inhibition of telomerase activity and bcl-2 expression in berbamine-induced apoptosis in HL-60 cells.Planta Med.200268759660010.1055/s‑2002‑32896 12142991
     [Google Scholar]
  67. LiuC.X. XiaoP.G. LiuG.S. Studies on plant resources, pharmacology and clinical treatment with berbamine.Phytother. Res.19915522823010.1002/ptr.2650050508
     [Google Scholar]
  68. YinL. ZhangL. LuoL. Berbamine reduces body weight via suppression of small GTPase Rab8a activity and activation of paraventricular hypothalamic neurons in obese mice.Eur. J. Pharmacol.202291617467910.1016/j.ejphar.2021.174679 34982965
     [Google Scholar]
  69. ZhaoY. LvJ.J. ChenJ. Berbamine inhibited the growth of prostate cancer cells in vivo and in vitro via triggering intrinsic pathway of apoptosis.Prostate Cancer Prostatic Dis.201619435836610.1038/pcan.2016.29 27431500
     [Google Scholar]
  70. HuangZ.Y. DongQ.H. Experimental study of berbamine inducing apoptosis in human leukemia jurkat cells.Bull Chin Cancer2007919
     [Google Scholar]
  71. ZhangX. SunJ. XuR. HeZ. GuY. Roles of phosphorylated p210bcr/abl and hsp90 protein in apoptosis induced by berbamine in K562 cells.Blood200610811441810.1182/blood.V108.11.4418.4418
     [Google Scholar]
  72. RamakrishnaK. NallaL.V. NareshD. WNT-β catenin signaling as a potential therapeutic target for neurodegenerative diseases: current status and future perspective.Diseases20231138910.3390/diseases11030089 37489441
     [Google Scholar]
  73. ZhangH. JiaoY. ShiC. Berbamine suppresses cell proliferation and promotes apoptosis in ovarian cancer partially via the inhibition of Wnt/β-catenin signaling.Acta Biochim. Biophys. Sin.)201850653253910.1093/abbs/gmy036 29701777
     [Google Scholar]
  74. LiuL. LiangD. ZhengQ. Berbamine dihydrochloride suppresses the progression of colorectal cancer via RTKs/Akt axis.J. Ethnopharmacol.202330311602510.1016/j.jep.2022.116025 36496042
     [Google Scholar]
  75. KimY.J. HanJ.M. JungH.J. Antiangiogenic and antitumor potential of berbamine, a natural CaMKIIγ inhibitor, against glioblastoma.Biochem. Biophys. Res. Commun.202156612913410.1016/j.bbrc.2021.06.025 34119825
     [Google Scholar]
  76. SunJ.R. ZhangX.H. HeZ.W. The mechanism of apoptosis of chronic myeloid leukemia cells induced by the novel p210 bcr/abl inhibitor berbamine.Zhonghua Yi Xue Za Zhi2006863222462251 17064567
     [Google Scholar]
  77. HeZ.W. ZhaoX.Y. XuR.Z. WuD. Effects of berbamine on growth of leukemia cell line NB4 and its mechanism.Zhejiang Da Xue Xue Bao Yi Xue Ban2006352209214 16610091
     [Google Scholar]
  78. XuH. KongY. ChenY. LiN. ZhangS. LuH. Natural plant extract berbamine is a potent inhibitor of cell growth and survival of human tenon’s fibroblasts.Ophthalmic Res.202063655556310.1159/000506644 32079013
     [Google Scholar]
  79. LiuX.Y. ChenG.N. DuG.M. Berbamine ameliorates ethanol-induced liver injury by inhibition of hepatic inflammation in mice.Chin. J. Nat. Med.202018318619510.1016/S1875‑5364(20)30020‑0 32245588
     [Google Scholar]
  80. MouL. LiangB. LiuG. Berbamine exerts anticancer effects on human colon cancer cells via induction of autophagy and apoptosis, inhibition of cell migration and MEK/ERK signalling pathway.JBUON201924518701875 31786849
     [Google Scholar]
  81. ZhangM.Y. YuY.Y. WangS.F. Cardiotoxicity evaluation of nine alkaloids from Rhizoma Coptis.Hum. Exp. Toxicol.201837218519510.1177/0960327117695633 29233041
     [Google Scholar]
  82. ConsoliniA.E. RagoneM.I. BonazzolaP. ColaredaG.A. Mitochondrial bioenergetics during ischemia and reperfusion.Adv. Exp. Med. Biol.201798214116710.1007/978‑3‑319‑55330‑6_8 28551786
     [Google Scholar]
  83. KurianG.A. RajagopalR. VedanthamS. RajeshM. The role of oxidative stress in myocardial ischemia and reperfusion injury and remodeling: Revisited.Oxidative Med Cell Longev20162016
     [Google Scholar]
  84. GuoZ.B. CaoH.Y. XuZ. LiQ. Electrophysiological effects of berbamine on ischemic ventricular tachyarrhythmia.Chung Kuo Yao Li Hsueh Pao19911214447 1950584
     [Google Scholar]
  85. ZhangW. Mechanism of the protective effects of berbamine on ischemia-reperfusion injury in isolated rat heart.Zhonghua Xin Xue Guan Bing Za Zhi1993215300303, 316-317 8200315
     [Google Scholar]
  86. SotníkováR. Ko št’álová D, Vaverková. Effect of bisbenzylisoquinoline alkaloids from Mahonia aquifolium on the isolated rat aorta.Gen. Pharmacol.19942571405141010.1016/0306‑3623(94)90165‑1 7896052
     [Google Scholar]
  87. XuC.Q. DongD.L. DuZ.M. ChenQ.W. GongD.M. YangB.F. Comparison of the anti-arrhythmic effects of matrine and berbamine with amiodarone and RP58866.Yao Xue Xue Bao2004399691694 15606015
     [Google Scholar]
  88. YangB.F. WangX.H. LiY. LiW.H. Effect of berbamine hydrochloride on experimentally-induced arrhythmias.Yao Xue Xue Bao1987229700703 2833064
     [Google Scholar]
  89. YangB.F. LiB. WuX. LiW.H. Effects of berbamine HCl on isolated working heart of guinea pig.Chin Pharmacol Bull1987
     [Google Scholar]
  90. ChenQ. YangL. ZhangY. YangB. LiW. Protective effect of berbamine on the arrhythmias and the myocardial infarction induced by ischemia in rats.J Harbin Med Univ1994289697
     [Google Scholar]
  91. XuC. LiuY. YangJ. Effects of berbamine against myocardial ischemia/reperfusion injury: Activation of the 5′ adenosine monophosphate-activated protein kinase/nuclear factor erythroid 2-related factor pathway and changes in the mitochondrial state.Biofactors202248365166410.1002/biof.1820 35129229
     [Google Scholar]
  92. QiaoG.F. ZhouH. LiB.Y. LiW.H. Antagonistic effects of berbamine on [Ca2+]i mobilization by KCl, norepinephrine, and caffeine in newborn rat cardiomyocytes.Chung Kuo Yao Li Hsueh Pao1999204292296 10452111
     [Google Scholar]
  93. LiF.L. BaoL.H. LiW.H. The effects of berbamine on the isolated guinea-pig atria.Yao Xue Xue Bao19852011859862 3835795
     [Google Scholar]
  94. ZhangC.M. GaoL. ZhengY.J. YangH.T. Berbamine increases myocardial contractility via a Ca2+-independent mechanism.J. Cardiovasc. Pharmacol.2011581404810.1097/FJC.0b013e31821b70d1 21753257
     [Google Scholar]
  95. LiB.Y. QiaoG.F. ZhaoY.L. ZhouH. LiW.H. Effects of berbamine on ATP-induced [Ca2+]i mobilization in cultured vascular smooth muscle cells and cardiomyocytes.Chung Kuo Yao Li Hsueh Pao1999208705708 10678102
     [Google Scholar]
  96. LiB.Y. YangB.F. LiW.H. Effects of berbamine on hemodynamics and myocardial reperfusion injury in isolated working rabbit hearts.Chung Kuo Yao Li Hsueh Pao19911214852 1950585
     [Google Scholar]
  97. LiB.Y. FuB. ZhaoY.L. LiW.H. Effects of berbamine on intracellular calcium concentration in cultured HeLa cells.Chung Kuo Yao Li Hsueh Pao1999201110111014 11270966
     [Google Scholar]
  98. LiB.Y. ZhangY.C. LiW.H. Effects of berbamine on contraction and Ca2+ influx of pig basilar artery.Chung Kuo Yao Li Hsueh Pao1992135412416 1300042
     [Google Scholar]
  99. WangM. SunJ. YangL. YangB.F. LiW.H. Protective effect of berbamine on the myocardial ischemia induced by pituitrin in rats.J Harbin Med Univ1994289495
     [Google Scholar]
  100. ZhaoY. QiaoG. ZhouH. LiB. Effects of berbamine on KC1, ouabain induced [Ca~2+]i elevation in rabbit VSMCs.J Harbin Med Univ199933265268
     [Google Scholar]
  101. WuX. Effects of Berbamine on Action Potential of Cardiac Purkinje cell of Dog.J Harbin Med Univ198741
     [Google Scholar]
  102. SunS. GaoY. LiW.H. Study on the mechanism of relaxation of berbamine on the isolated rabbit renal arteries.Chin Pharmacol Bull198620
     [Google Scholar]
  103. LuoD. GaoY. LiW.H. The mechanism of dilating vascular smooth muscle by n-methylberbamine.Chin Pharmacol Bull198711
     [Google Scholar]
  104. SunS. Study of relaxation mechanisms of berbamine on the isolated rabbit mesenteric arteries.J Harbin Med Univ198842
     [Google Scholar]
  105. BaoL. LiF. LiW.H. The protective effect of berbamine on cerebral infarction model in rats.Chin Pharmacol Bull1987
     [Google Scholar]
  106. LeeH.J. JeongH.S. KimD.J. NohY.H. YukD.Y. HongJ.T. Inhibitory effect of citral on NO production by suppression of iNOS expression and NF-κB activation in RAW264. 7 cells.Arch. Pharm. Res.200831334234910.1007/s12272‑001‑1162‑0 18409048
     [Google Scholar]
  107. MengZ. YanC. DengQ. GaoD. NiuX. Curcumin inhibits LPS-induced inflammation in rat vascular smooth muscle cells in vitro via ROS-relative TLR4-MAPK/NF-κB pathways.Acta Pharmacol. Sin.201334790191110.1038/aps.2013.24 23645013
     [Google Scholar]
  108. BjarnasonI. ScarpignatoC. HolmgrenE. OlszewskiM. RainsfordK.D. LanasA. Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs.Gastroenterology2018154350051410.1053/j.gastro.2017.10.049 29221664
     [Google Scholar]
  109. KüpeliE. Koşar M, Yeşilada E, Başer KHC, Başer C. A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species.Life Sci.200272664565710.1016/S0024‑3205(02)02200‑2 12467905
     [Google Scholar]
  110. SeowW.K. FerranteA. SummorsA. ThongY.H. Comparative effects of tetrandrine and berbamine on production of the inflammatory cytokines interleukin-1 and tumor necrosis factor.Life Sci.1992508PL53PL5810.1016/0024‑3205(92)90373‑W 1310515
     [Google Scholar]
  111. RenY. LuL. GuoT.B. Novel immunomodulatory properties of berbamine through selective down-regulation of STAT4 and action of IFN-γ in experimental autoimmune encephalomyelitis.J. Immunol.200818121491149810.4049/jimmunol.181.2.1491 18606704
     [Google Scholar]
  112. TehB.S. SeowW.K. LiS.Y. ThongY.H. Inhibition of prostaglandin and leukotriene generation by the plant alkaloids tetrandrine and berbamine.Int. J. Immunopharmacol.199012332132610.1016/0192‑0561(90)90088‑5 2109734
     [Google Scholar]
  113. WongC.W. SeowW.K. O’CallaghanJ.W. ThongY.H. Comparative effects of tetrandrine and berbamine on subcutaneous air pouch inflammation induced by interleukin-1, tumour necrosis factor and platelet-activating factor.Agents Actions1992361-211211810.1007/BF01991238 1414679
     [Google Scholar]
  114. WongC.W. SeowW.K. ThongY.H. Comparative effects of tetrandrine and berbamine on acute and relapsing experimental allergic encephalitis in Lewis rats.Int. Arch. Allergy Immunol.1992971313610.1159/000236092 1582695
     [Google Scholar]
  115. YadavS.K. RaiS.N. SinghS.P. Mucuna pruriens reduces inducible nitric oxide synthase expression in Parkinsonian mice model.J. Chem. Neuroanat.20178011010.1016/j.jchemneu.2016.11.009 27919828
     [Google Scholar]
  116. RaiS.N. YadavS.K. SinghD. SinghS.P. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.J. Chem. Neuroanat.201671414910.1016/j.jchemneu.2015.12.002 26686287
     [Google Scholar]
  117. PrakashJ. ChouhanS. YadavS.K. WestfallS. RaiS.N. SinghS.P. Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons.Neurochem. Res.201439122527253610.1007/s11064‑014‑1443‑7 25403619
     [Google Scholar]
  118. RaiSN ChaturvediVK SinghP SinghBK SinghMP Mucuna pruriens in Parkinson’s and in some other diseases: recent advancement and future prospective.3 Biotech2020101252210.1007/s13205‑020‑02532‑733194526
     [Google Scholar]
  119. FaheemM. KhanA. SaleemM.W. Neuroprotective effect of natural compounds in paclitaxel-induced chronic inflammatory pain.Molecules20222715492610.3390/molecules27154926 35956877
     [Google Scholar]
  120. JuH.S. HanZ.W. Antioxidant effect of berbamine.Chung Kuo Yao Li Hsueh Pao1990116539541 1966656
     [Google Scholar]
  121. BezákováL. MisikV. MálekováL. SvajdlenkaE. KostálováD. Lipoxygenase inhibition and antioxidant properties of bisbenzylisoqunoline alkaloids isolated from Mahonia aquifolium.Pharmazie19965110758761 8941945
     [Google Scholar]
  122. Classification and diagnosis of diabetes.Diabetes Care201538Suppl. 1S8S1610.2337/dc15‑S005 25537714
     [Google Scholar]
  123. KleinbergerJ.W. PollinT.I. Personalized medicine in diabetes mellitus: current opportunities and future prospects.Ann. N. Y. Acad. Sci.201513461455610.1111/nyas.12757 25907167
     [Google Scholar]
  124. DubeyS.K. RaiS.N. SinghV.K. BajpeyeeA.K. SinghM.P. Evaluation of pleurotus mushroom effects on histopathological changes in organs of diabetic rats.Dis. Markers202320231810.1155/2023/1520132 37091893
     [Google Scholar]
  125. TangX. FengH. GaoJ. Effect of berbamine hydrochloride on the absorption of berberine hydrochloride in an in situ single-pass intestinal perfusion system in rats.Trop. J. Pharm. Res.202221478779410.4314/tjpr.v21i4.15
     [Google Scholar]
  126. LuoC.N. BienQ.Y. LinX. WanL.W. XiaoP.G. Berbamine inhibits IL-2 receptor expression, but spares IL-2 production and its mRNA expression.Phytomedicine19985426927310.1016/S0944‑7113(98)80065‑2 23195898
     [Google Scholar]
  127. LuoC. LinX. LiW. Study on the immunosuppressive effects of berbamine and its mechanism.Phytother. Res.199711858558710.1002/(SICI)1099‑1573(199712)11:8<585::AID‑PTR151>3.0.CO;2‑K
     [Google Scholar]
  128. LiS. LingL-H. TehB.S. SeowW.K. ThongY.H. Anti-inflammatory and immunosuppressive properties of the bis-benzylisoquinolines: In vitro comparisons of tetrandrine and berbamine.Int. J. Immunopharmacol.198911439540110.1016/0192‑0561(89)90086‑6 2777433
     [Google Scholar]
  129. SunB. LiW. GaoY. Study on the effect of berbamine and oil of Heidouguo on blood lipid disorder in rats.J Harbin Med Univ199630332334
     [Google Scholar]
  130. SharmaA. AnandS.K. SinghN. DwivediU.N. KakkarP. Berbamine induced AMPK activation regulates mTOR/SREBP-1c axis and Nrf2/ARE pathway to allay lipid accumulation and oxidative stress in steatotic HepG2 cells.Eur. J. Pharmacol.202088217324410.1016/j.ejphar.2020.173244 32526241
     [Google Scholar]
  131. SharmaA. AnandS.K. SinghN. DwarkanathA. DwivediU.N. KakkarP. Berbamine induced activation of the SIRT1/LKB1/AMPK signaling axis attenuates the development of hepatic steatosis in high-fat diet-induced NAFLD rats.Food Funct.202112289290910.1039/D0FO02501A 33411880
     [Google Scholar]
  132. YeZ. Van DykeK. YangB. Interaction of berbamine and chloroquine or artemisinin against chloroquine-sensitive and -resistant plasmodium falciparum in vitro.Drug Dev. Res.199330422923710.1002/ddr.430300405
     [Google Scholar]
  133. RyuK. HeoY. LeeY. JeonH. NamkungW. Berbamine reduces chloroquine-induced itch in mice through inhibition of MrgprX1.Int. J. Mol. Sci.202223221432110.3390/ijms232214321 36430803
     [Google Scholar]
  134. KirkwoodN.K. O’ReillyM. DerudasM. d-Tubocurarine and berbamine: Alkaloids that are permeant blockers of the hair cell’s mechano-electrical transducer channel and protect from aminoglycoside toxicity.Front. Cell. Neurosci.20171126210.3389/fncel.2017.00262 28928635
     [Google Scholar]
  135. HudsonA.M. LockardG.M. NamjoshiO.A. Berbamine Analogs Exhibit Differential Protective Effects From Aminoglycoside-Induced Hair Cell Death.Front. Cell. Neurosci.20201423410.3389/fncel.2020.00234 32848624
     [Google Scholar]
  136. ChenC. WangH. QianF. Prominent effects of berbamine hydrochloride on Alzheimer’s disease model mice.Front. Pharmacol.20221393903910.3389/fphar.2022.939039 35846991
     [Google Scholar]
  137. DongL. XieH.Z. JiaL. HongL. LiG. Inhibition of amyloid β aggregation and cytotoxicity by berbamine hydrochloride.Chem-A Eur J202329e202301865
     [Google Scholar]
  138. QiG. JiangZ. LuW. Berbamine inhibits RANKL- and M-CSF-mediated osteoclastogenesis and alleviates ovariectomy-induced bone loss.Front. Pharmacol.202213103286610.3389/fphar.2022.1032866 36408260
     [Google Scholar]
  139. ZhangC. ZhongZ. SangW. The dibenzyl isoquinoline alkaloid berbamine ameliorates osteoporosis by inhibiting bone resorption.Front. Endocrinol.20221388550710.3389/fendo.2022.885507 35663327
     [Google Scholar]
  140. ZhangS. ZhouX. OuM. Berbamine promotes macrophage autophagy to clear Mycobacterium tuberculosis by regulating the ROS/Ca 2+ axis.MBio2023144e00272e2310.1128/mbio.00272‑23 37382506
     [Google Scholar]
  141. YuB. LiuL. YanJ. CaoJ. CaoY. Effect of berbamine on invasion and metastasis of human liver cancer SMMC-7721 cells and its possible mechanism.Anticancer Drugs2022331e178e18510.1097/CAD.0000000000001179 34321418
     [Google Scholar]
  142. HanJ.M. JungH.J. Synergistic anticancer effect of a combination of berbamine and arcyriaflavin A against glioblastoma stem-like cells.Molecules20222722796810.3390/molecules27227968 36432068
     [Google Scholar]
  143. WangL. LyuC. StadlbauerB. BuchnerA. NößnerE. PohlaH. Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p-STAT3 in prostate cancer.Prostate202484213114710.1002/pros.24632 37828768
     [Google Scholar]
  144. ChenG. HuB. YangY. Berbamine exerts an anti-oncogenic effect on pancreatic cancer by regulating wnt and dna damage-related pathways.Anticancer. Agents Med. Chem.202323220120910.2174/1871520622666220509174306 35579129
     [Google Scholar]
  145. CuiD. ZhangW-J. ZhengW-W. MeiC-Z. Effect of berbamine combined with ibrutinib on the proliferation and apoptosis of acute myeloid leukemia cells.Zhongguo Shi Yan Xue Ye Xue Za Zhi202230616431649 36476883
     [Google Scholar]
  146. ZhaoW. BaiB. HongZ. ZhangX. ZhouB. Berbamine (BBM), a natural stat3 inhibitor, synergistically enhances the antigrowth and proapoptotic effects of sorafenib on hepatocellular carcinoma cells.ACS Omega2020538248382484710.1021/acsomega.0c03527 33015502
     [Google Scholar]
  147. TianH. PanQ.C. A comparative study on effect of two bisbenzylisoquinolines, tetrandrine and berbamine, on reversal of multidrug resistance.Yao Xue Xue Bao1997324245250 11499024
     [Google Scholar]
  148. HanY.Q. YuanJ.Y. ShiY.J. ZhuY. WuS.L. Reversal effect of berbamine on multidrug resistance of K562/A02 cells and its mechanism.Zhongguo Shi Yan Xue Ye Xue Za Zhi2003116604608 14706144
     [Google Scholar]
  149. HanY. WuS. Berbamine Down-regulating Survivin mRNA Expression in MCF7 and MCF7/ADR Cells.J Chin Phy2001
     [Google Scholar]
  150. HanY. ShiY. YuanJ. ZhuY. WuS. The study of reversal resistance effect and its mechanism of berbamine in MCF7/ADR cells.Acta Anatomic Sin200435161164
     [Google Scholar]
  151. LiuJ. QiS. ZhuH. ZhangJ. LiZ. WangT. The effect of calmodulin antagonist berbaminederivative-EBB on hepatoma in vitro and in vivo.Chin. Med. J.20021155759762 12133551
     [Google Scholar]
  152. LiuR. ZhangY. ChenY. A novel calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine overcomes multidrug resistance in drug-resistant MCF-7/ADR breast carcinoma cells.J. Pharm. Sci.20109973266327510.1002/jps.22082 20112430
     [Google Scholar]
  153. ZhangH. ZhuT. FuR. Combination of detoxified pneumolysin derivative ΔA146Ply and berbamine as a treatment approach for breast cancer.Mol. Ther. Oncolytics20201824726110.1016/j.omto.2020.06.015 32728613
     [Google Scholar]
  154. CuiY. XuM. MaoJ. OuyangJ. XuR. YuY. Synthesis of berbamine acetyl glycosides and evaluation of antitumor activity.Eur. J. Med. Chem.20125486787210.1016/j.ejmech.2012.04.042 22633009
     [Google Scholar]
  155. ZhangL. XuR. LiL. ZhaoX. HuangJ. The novel berbamine derivative, cbbm, downregulates c-myc to block diffuse large b-cell lymphoma cell maintenance.Blood2018132Suppl. 121210.1182/blood‑2018‑99‑112006
     [Google Scholar]
  156. DaiX.H. LiuR. ZhouY. Effect of calmodulin antagonist O-4-ethoxyl- butyl-berbamine on the proliferation of human breast cancer cell line MCF-7 and its relevant mechanism.Zhongguo Yi Xue Ke Xue Yuan Xue Bao2009313326329 19621518
     [Google Scholar]
  157. ZouL.L. ZhouY. YangM. The Growth inhibiting effect of calmodulin antagonist O-(4-ethoxiyl-butyl)-berbamine on leukemia cells K562 and K562/A02.Chin Pharmacol Bull20091019
     [Google Scholar]
  158. Zhuo-YiH. Yue-ShongG. Wen-LongH. Interaction of berbamine compound E6 and calmodulin-dependent myosin light chain kinase.Biochem. Pharmacol.19924481543154710.1016/0006‑2952(92)90470‑4 1417979
     [Google Scholar]
  159. NamS. XieJ. PerkinsA. Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells.Mol. Oncol.20126548449310.1016/j.molonc.2012.05.002 22717603
     [Google Scholar]
  160. ShenJ.K. DuH.P. MaQ. YangM. WangY.G. JinJ. 4-Chlorobenzoyl berbamine, a novel berbamine derivative, induces apoptosis in multiple myeloma cells through the IL-6 signal transduction pathway and increases FOXO3a-Bim expression.Oncol. Rep.201330142543210.3892/or.2013.2431 23624712
     [Google Scholar]
  161. YangF. NamS. ZhaoR. TianY. HorneD. JoveR. A novel berbamine derivative induces apoptosis of chemotherapy-resistant human osteosarcoma cells through activation of ROS/JNK signaling.Mol. Cell. Biol.2012728Suppl.20699
     [Google Scholar]
  162. YangF. NamS. ZhaoR. A novel synthetic derivative of the natural product berbamine inhibits cell viability and induces apoptosis of human osteosarcoma cells, associated with activation of JNK/AP-1 signaling.Cancer Biol. Ther.201314111024103110.4161/cbt.26045 24025361
     [Google Scholar]
  163. YangF. NamS. BrownC.E. A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling.PLoS One201494e9444310.1371/journal.pone.0094443 24732116
     [Google Scholar]
  164. YuQ. WangP. YangL. Novel synthetic tosyl chloride-berbamine regresses lethal MYC-positive leukemia by targeting CaMKIIγ/Myc axis.Biomed. Pharmacother.201911710913410.1016/j.biopha.2019.109134
     [Google Scholar]
  165. LiW. LiY. TianW. 2-methylbenzoyl berbamine, a multi-targeted inhibitor, suppresses the growth of human osteosarcoma through disabling NF-κB, ERK and AKT signaling networks.Aging (Albany NY)20201214150371504910.18632/aging.103565 32713851
     [Google Scholar]
  166. ZhangY.F. XuG.B. GanY.C. XuX.H. XuR.Z. Inhibitory effect of 4-chlorobenzoyl berbamine on imatinib-resistant K562 cells in vitro and in vivo.Nan Fang Yi Ke Da Xue Xue Bao2011311219972001 22200699
     [Google Scholar]
  167. LiangY. HeX. LiX. 4-Chlorbenzoyl berbamine, a novel derivative of the natural product berbamine, potently inhibits the growth of human myeloma cells by modulating the NF-κB and JNK signaling pathways.Cancer Invest.2016341049650510.1080/07357907.2016.1235709 27768381
     [Google Scholar]
  168. XieJ. MaT. GuY. Berbamine derivatives: A novel class of compounds for anti-leukemia activity.Eur. J. Med. Chem.20094483293329810.1016/j.ejmech.2009.02.018 19285759
     [Google Scholar]
  169. ZhengG.H. ChenZ.L. JiangJ.H. Effects of O-(4-ethoxyl-butyl)-berbamine on isolated frog hearts.Chung Kuo Yao Li Hsueh Pao1998195497500 10375820
     [Google Scholar]
  170. HuH. ZhouS. SunX. A potent antiarrhythmic drug N-methyl berbamine extends the action potential through inhibiting both calcium and potassium currents.J. Pharmacol. Sci.2020142413113910.1016/j.jphs.2019.12.008 31992491
     [Google Scholar]
  171. XuS. WuS. ZhangM. Pharmacological profiling of a berbamine derivative for lymphoma treatment.Blood Adv.20248230932310.1182/bloodadvances.2023010873 37967356
     [Google Scholar]
  172. HuZ. LiS. YangL. Preparation of berbamine loaded chitosan-agarose microspheres and in vitro release study.Polímeros201222542242610.1590/S0104‑14282012005000073
     [Google Scholar]
  173. ParhiP. SuklabaidyaS. Kumar SahooS. Enhanced anti-metastatic and anti-tumorigenic efficacy of Berbamine loaded lipid nanoparticles in vivo.Sci. Rep.201771580610.1038/s41598‑017‑05296‑y 28724926
     [Google Scholar]
  174. WuJ. BuX. DouL. FangL. ShenQ. Co-delivery of Docetaxel and Berbamine by Chitosan/Sulfobutylether-β-Cyclodextrin nanoparticles for enhancing bioavailability and anticancer activities.J. Biomed. Nanotechnol.201511101847185710.1166/jbn.2015.2110 26502647
     [Google Scholar]
  175. ZhuL. ZhangB. LuX. ShuY. LiuB. Delivery of paclitaxel and berbamine by polymeric carriers to cure gastric cancer.Oncol. Res.201320726527410.3727/096504012X13522227232318 23879166
     [Google Scholar]
  176. TangZ. NiuY. XuZ. Anti-tumor and anti-metastasis effects of berbamine-loaded lipid nanoparticles on pancreatic cancer.Anticancer. Agents Med. Chem.202222183097310610.2174/1871520622666220501161636 35490430
     [Google Scholar]
  177. HuangL. LiH. YuenT.T.T. Berbamine inhibits the infection of SARS-CoV-2 and flaviviruses by compromising TPRMLs-mediated endolysosomal trafficking of viral receptors.Research Square202010.21203/rs.3.rs‑30922/v1
     [Google Scholar]
  178. BehlT. SinghS. SharmaN. Expatiating the pharmacological and nanotechnological aspects of the alkaloidal drug berberine: current and future trends.Molecules20222712370510.3390/molecules27123705 35744831
     [Google Scholar]
  179. FatimaN. BaqriS.S.R. AlsulimaniA. Phytochemicals from indian ethnomedicines: promising prospects for the management of oxidative stress and cancer.Antioxidants20211010160610.3390/antiox10101606 34679741
     [Google Scholar]
  180. JoshiT. BhatS. PundirH. ChandraS. Identification of berbamine, oxyacanthine and rutin from berberis asiatica as anti-sars-cov-2 compounds: an in silico study.J. Mol. Graph. Model.202110910802810.1016/j.jmgm.2021.108028 34649146
     [Google Scholar]
  181. ClohertyA.P.M. RaderA.G. PatelK.S. Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade.Emerg. Microbes Infect.2023121219502010.1080/22221751.2023.2195020 36951188
     [Google Scholar]
  182. ZhangZ.R. ZhangY.N. ZhangH.Q. Berbamine hydrochloride potently inhibits SARS-CoV-2 infection by blocking S protein-mediated membrane fusion.PLoS Negl. Trop. Dis.2022164e001036310.1371/journal.pntd.0010363 35468133
     [Google Scholar]
  183. HuangL. LiH. YeZ. Berbamine inhibits Japanese encephalitis virus (JEV) infection by compromising TPRMLs-mediated endolysosomal trafficking of low-density lipoprotein receptor (LDLR).Emerg. Microbes Infect.20211011257127110.1080/22221751.2021.1941276 34102949
     [Google Scholar]
  184. LiZ. HeY. GeL. Berbamine, a bioactive alkaloid, suppresses equine herpesvirus type 1 in vitro and in vivo.Front. Vet. Sci.202310116378010.3389/fvets.2023.1163780 37303732
     [Google Scholar]
  185. YiD. LiQ. WangH. Repurposing of berbamine hydrochloride to inhibit Ebola virus by targeting viral glycoprotein.Acta Pharm. Sin. B202212124378438910.1016/j.apsb.2022.05.023 36561997
     [Google Scholar]
  186. ZhuJ. HuangL. GaoF. Berbamine hydrochloride inhibits African swine fever virus infection in vitro.Molecules202228117010.3390/molecules28010170 36615369
     [Google Scholar]
  187. WangJ. YangG. ZhangL. Berbamine hydrochloride inhibits bovine viral diarrhea virus replication via interfering in late-stage autophagy.Virus Res.202232119890510.1016/j.virusres.2022.198905 36064041
     [Google Scholar]
  188. WangH-j LiS LianR DongQ-t HeY-t JiaX Antiviral effect in vitro and mechanism study based on type I interferon pathway of berbamine.2023
     [Google Scholar]
/content/journals/ctmc/10.2174/0115680266289292240420062705
Loading
Pharmacological and Therapeutic Potential of Berbamine: A Potent Alkaloid from Genus Berberis
Curr. Top. Med. Chem. 25, 891 (2025); https://doi.org/10.2174/0115680266289292240420062705
/content/journals/ctmc/10.2174/0115680266289292240420062705
/content/journals/ctmc/10.2174/0115680266289292240420062705
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Anti-proliferative; Apoptosis; Berbamine; Cytotoxic; Ischemia; Myocardial infarction

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test